4.6 Article

Medical student attitudes and perceptions of psychedelic-assisted therapies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychology, Clinical

Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia

Nicolas G. Glynos et al.

Summary: This study aimed to explore the knowledge, perceptions, and past use of psychedelic substances among individuals with FM, and their interest in psychedelic-based treatments. The findings showed that a significant portion of FM patients have used psychedelics and reported improvements in their symptoms. The majority of participants believed in the potential of psychedelic substances for chronic pain treatments and expressed willingness to participate in clinical trials.

JOURNAL OF PSYCHOACTIVE DRUGS (2023)

Article Psychology, Clinical

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Classical Psychedelics

Aviad Hadar et al.

Summary: This article characterizes, analyzes, and visualizes trends in the top-cited articles of the psychedelic research field. The study finds significant research growth in the past decade, with the UK, USA, and other countries leading the field. The aggregated data and insights provide guidance for future research, funding policies, and researchers and clinicians entering the field.

JOURNAL OF PSYCHOACTIVE DRUGS (2023)

Article Medicine, General & Internal

Predictors of Medical Students? Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice

Karina Wang et al.

Summary: Psilocybin use has gained interest in the medical community for its therapeutic potential. However, medical students receive minimal training on psilocybin due to its classification as a Schedule 1 drug. This study aimed to assess medical students' perceptions of psilocybin and found that greater knowledge and belief in legalization predicted positive attitudes towards its medical use.

CUREUS JOURNAL OF MEDICAL SCIENCE (2023)

Article Psychology, Clinical

Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey

Brian S. Barnett et al.

Summary: Despite a resurgence in interest in psychedelic-assisted therapy, our understanding of psychiatrists' knowledge and opinions regarding medicinal psychedelic applications is limited. An anonymous survey of psychiatrists attending psychedelic didactic presentations at national meetings revealed that a majority believe in the treatment potential of psychedelics and support federal funding for research in this area. However, concerns were raised about the lack of trained providers, logistics of therapy delivery, contraindications, and diversion. Desired educational topics included potential benefits, how to conduct therapy, pharmacology, and side effects of psychedelics.

JOURNAL OF PSYCHOACTIVE DRUGS (2022)

Article Psychology, Clinical

Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

Alan K. Davis et al.

Summary: Psychologists show cautiously positive attitudes towards psychedelic-assisted therapy, but express concerns about potential risks and lack comprehensive understanding of psychedelics. They believe in the potential of psychedelic treatment, endorse the need for further research, and emphasize the importance of increasing education and training about psychedelics to reduce stigma.

JOURNAL OF PSYCHOACTIVE DRUGS (2022)

Article Medicine, General & Internal

Psychedelic perceptions: mental health service user attitudes to psilocybin therapy

Kate Corrigan et al.

Summary: The majority of mental health service users support further research into psilocybin therapy. Younger individuals, those with previous recreational psychedelic experience, and those with non-religious beliefs are more likely to have favorable attitudes towards psilocybin therapy. A minority of participants believe psychedelics are addictive and unsafe even under medical supervision.

IRISH JOURNAL OF MEDICAL SCIENCE (2022)

Article Clinical Neurology

Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms

Emma Kopra et al.

Summary: This study investigated the prevalence and nature of adverse reactions resulting in emergency medical treatment seeking in a global sample of magic mushroom users. The results showed that magic mushrooms are a relatively safe drug, with serious incidents rare and short lasting. Young age was the only predictor associated with higher risk of emergency medical presentations.

JOURNAL OF PSYCHOPHARMACOLOGY (2022)

Article Psychology, Applied

Counselors' attitudes toward psychedelics and their use in therapy

Benjamin G. Hearn et al.

Summary: The ''psychedelic renaissance'' is providing new evidence for the potential of psychedelic drugs in treating mental and substance use disorders. The US FDA is expected to approve MDMA and psilocybin for psychedelic-assisted therapy. Despite the increasing public attention and changes in legal status, the counseling profession has not been actively engaged in the research and discussions surrounding psychedelics. A survey of counseling professionals reveals mixed attitudes towards psychedelic use and psychedelic-assisted therapy, with most counselors recognizing the need for further research.

JOURNAL OF COUNSELING AND DEVELOPMENT (2022)

Article Health Policy & Services

The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey

Lisa M. Reynolds et al.

Summary: The research suggests that psychedelic-assisted therapy is a promising intervention for anxiety, depression, and existential distress in people with cancer. Healthcare practitioners in New Zealand and the USA perceive the potential benefits of psychedelic treatment, emphasizing the importance of research and considering spiritual and indigenous perspectives in therapy.

PALLIATIVE & SUPPORTIVE CARE (2022)

Article Health Care Sciences & Services

Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies

Halsey Niles et al.

Summary: This study aimed to understand the attitudes of palliative care clinicians towards treatments for existential distress, finding that palliative care providers see existential distress as often insufficiently treated in the current framework; believe PAT hold promise for treating existential distress but require stronger evidence; larger clinical trials and educational outreach are needed for adapting PAT to palliative care settings and addressing safety concerns.

BMC PALLIATIVE CARE (2021)

Article Psychiatry

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy

Lisa A. Page et al.

Summary: The study explored the attitudes and knowledge of NHS psychiatrists towards psychedelic-assisted psychotherapy and identified potential barriers and facilitators to its implementation. Despite positive views on the potential of psychedelic therapy, psychiatrists felt unprepared to deliver this treatment if it becomes mainstream. Training needs and the need for societal and professional shifts were highlighted as key findings from the thematic analysis.

FRONTIERS IN PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer M. Mitchell et al.

Summary: The results demonstrate that MDMA-assisted therapy is safe and effective in treating severe post-traumatic stress disorder. Compared with placebo, MDMA significantly reduces CAPS-5 scores and improves functional impairment.

NATURE MEDICINE (2021)

Article Environmental Sciences

Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation

Lisa M. Reynolds et al.

Summary: This study examined the perceptions of cancer healthcare professionals on the potential use of psychedelic-assisted therapy in advanced cancer patients. The findings showed curiosity and openness among the professionals towards the idea, tempered by concerns over safety and the importance of conducting rigorous, well-designed trials. This study's results provide a valuable basis for future engagement with healthcare professionals regarding research, trial design, and potential clinical applications.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Neurosciences

Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders

Fiona Harding et al.

Summary: The study investigated the perspectives of people with eating disorders on the use of complementary therapies and psychedelic research and treatment. Majority of participants had tried complementary treatments and believed that psychedelic research was worthwhile to some extent. They emphasized the need for a safe, monitored environment and patient-therapist rapport in the context of psychedelic treatment.

JOURNAL OF INTEGRATIVE NEUROSCIENCE (2021)

Article Neurosciences

Psychedelic drugs-a new era in psychiatry?

David Nutt

DIALOGUES IN CLINICAL NEUROSCIENCE (2019)

Article Clinical Neurology

A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens

Brian S. Barnett et al.

JOURNAL OF NERVOUS AND MENTAL DISEASE (2018)

Article Health Care Sciences & Services

Colorado Medical Students' Attitudes and Beliefs About Marijuana

Michael H. Chan et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2017)

Article Neurosciences

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Robin L. Carhart-Harris et al.

NEUROPSYCHOPHARMACOLOGY (2017)

Review Pharmacology & Pharmacy

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

Rafael G. dos Santos et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)

Editorial Material Biochemistry & Molecular Biology

The stigma of mental disorders: A millennia-long history of social exclusion and prejudices

Wulf Roessler

EMBO REPORTS (2016)

Article Clinical Neurology

Psychedelics not linked to mental health problems or suicidal behavior: A population study

Pal-Orjan Johansen et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

Article Clinical Neurology

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Michael P. Bogenschutz et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

Article Clinical Neurology

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Matthew W. Johnson et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2014)

Article Multidisciplinary Sciences

Psychedelics and Mental Health: A Population Study

Teri S. Krebs et al.

PLOS ONE (2013)

Article Clinical Neurology

Measuring the stigma of psychiatry and psychiatrists: development of a questionnaire

Wolfgang Gaebel et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)

Article Substance Abuse

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

R. L. Carhart-Harris et al.

JOURNAL OF SUBSTANCE USE (2010)

Review Clinical Neurology

Human hallucinogen research: guidelines for safety

M. W. Johnson et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2008)